A new study in JAMA Health Forum by USC Schaeffer Center experts analyzes state and federal responses to the opioid crisis amidst the pandemic. The authors find that while all states and D.C. have adopted at least one policy related to treatment access for patients suffering from opioid addiction, zero states adopted all policies important to treatment access.
Despite its discovery nearly 100 years ago, insulin’s list price has been going up, not down. New Schaeffer Center research analyzes the flow of money across all distribution system participants—manufacturers, wholesalers, pharmacies, pharmacy benefit managers (PBMs), and health plans.
In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.